Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/515
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBonett, Michael-
dc.contributor.authorArthur, Niamh-
dc.contributor.authorVella Bonanno, Patricia-
dc.date.accessioned2014-11-27T08:36:37Z-
dc.date.available2014-11-27T08:36:37Z-
dc.date.issued2004-
dc.identifier.citationMalta Medical Journal. 2004, Vol.16(3), p. 31-33en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar//handle/123456789/515-
dc.description.abstractThe mission of the Medicines Authority (MA) in Malta is to contribute to protection of public health through regulation of the safety, quality and efficacy of medicines for human use on the local market and to ensure that healthcare professionals and patients have access to accurate and up to date information about medicines. In order to disseminate information regarding safety of medicines, the MA publishes guidance notes for healthcare professionals and the pharmaceutical industry. The MA also publishes information on its website: http://www.health.gov.mt/mru/ On the 4th of May, 2004 the MA held a seminar to launch a national adverse drug reaction (ADR) reporting system involving the co-operation of doctors, dentists and pharmacists, as well as the pharmaceutical industry. The ADR reporting system will form part of an overall pharmacovigilance system within the Authority and this will be the primary means of collecting information useful in the surveillance of medicinal products.en_GB
dc.language.isoenen_GB
dc.publisherMalta Medical Journalen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectPublic health -- Maltaen_GB
dc.subjectDrug monitoring -- Maltaen_GB
dc.subjectDrugs -- Administration -- Law and legislationen_GB
dc.titleA National Adverse Drug Reaction Reporting System for Maltaen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedpeer-reviewed-
Appears in Collections:MMJ, Volume 16, Issue 3
MMJ, Volume 16, Issue 3
Scholarly Works - FacHScHSM

Files in This Item:
File Description SizeFormat 
2004.Vol16.Issue3.A7-workingversion.pdfA National Adverse Drug Reaction Reporting System for Malta171.71 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.